ABPA — RACP Paediatrics MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: B — Allergic bronchopulmonary aspergillosis
Allergic bronchopulmonary aspergillosis (ABPA) should be considered in asthmatic or CF patients with worsening symptoms, elevated total IgE, eosinophilia, positive Aspergillus-specific IgE/IgG, and central bronchiectasis. Treatment is with systemic corticosteroids (prednisolone) and itraconazole.
Reference: RCH Melbourne – 2023 – CF CPG; Australian Therapeutic Guidelines – 2024 – Respiratory